Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation
X Thomas - Oncology and Therapy, 2024 - Springer
Recent advances have included insights into the clinical value of genomic abnormalities in
acute myeloid leukemia (AML) and consequently the development of numerous targeted …
acute myeloid leukemia (AML) and consequently the development of numerous targeted …
The Menin story in acute myeloid leukaemia—The road to success
MWM Kühn, A Ganser - British Journal of Haematology, 2024 - Wiley Online Library
The treatment of acute myeloid leukaemia (AML) has changed fundamentally in the last
decade with many new targeted therapies entering clinics. Some of the most interesting …
decade with many new targeted therapies entering clinics. Some of the most interesting …